EdgeRock Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-293
Closed -$145K 156
2023
Q4
$145K Buy
+293
New +$135K 0.11% 61
2022
Q4
Sell
-244
Closed -$111K 159
2022
Q3
$111K Buy
+244
New +$117K 0.06% 76

Other funds holding ELV

EdgeRock Capital's ELV Position: Q1 2024 in Review

EdgeRock Capital sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 293 shares — an estimated $145K sold.

EdgeRock Capital first reported a position in ELV in Q3 2022 and held it in 2 quarters. The position peaked at $145K in Q4 2023. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

  • EdgeRock Capital reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
  • EdgeRock Capital sold 293 Elevance Health shares in Q1 2024, an estimated $145K.
  • EdgeRock Capital first reported a position in Elevance Health in Q3 2022 and held it in 2 quarters.
  • EdgeRock Capital's Elevance Health position peaked at $145K in Q4 2023.
  • 1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on EdgeRock Capital's 13F filing for Q1 2024, filed 15 May 2024.